Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age (Q83322982)
Jump to navigation
Jump to search
scientific article published on 28 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age |
scientific article published on 28 January 2011 |
Statements
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age (English)
R Baxter
P A Patriarca
K Ensor
R Izikson
K L Goldenthal